Zacks Investment Research cut shares of Kindred Healthcare, Inc. (NYSE:KND) from a hold rating to a sell rating in a research note released on Wednesday, October 4th.

According to Zacks, “Kindred Healthcare, Inc. is one of the largest providers of long-term healthcare services in the United States. Their health services division provides long-term care services by operating nursing centers and a rehabilitation therapy business, and their hospital division provides long-term acute care services by operating hospitals and an institutional pharmacy business. “

Several other equities research analysts have also weighed in on KND. Mizuho restated a neutral rating and issued a $9.00 target price on shares of Kindred Healthcare in a report on Monday, July 3rd. BidaskClub lowered Kindred Healthcare from a buy rating to a hold rating in a report on Wednesday, July 12th. Deutsche Bank AG cut their price target on Kindred Healthcare from $13.00 to $10.00 and set a buy rating for the company in a report on Monday, August 7th. Royal Bank Of Canada cut their price target on Kindred Healthcare from $9.00 to $7.50 and set a sector perform rating for the company in a report on Thursday, September 21st. Finally, Bank of America Corporation cut their price target on Kindred Healthcare from $7.50 to $6.50 and set an underperform rating for the company in a report on Thursday, September 21st. Six research analysts have rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the stock. The company has a consensus rating of Hold and an average target price of $8.75.

Kindred Healthcare (NYSE:KND) traded down 2.44% during mid-day trading on Wednesday, hitting $6.00. 3,775,537 shares of the stock were exchanged. The firm’s market cap is $522.11 million. The company has a 50 day moving average price of $6.94 and a 200 day moving average price of $8.97. Kindred Healthcare has a 52-week low of $5.50 and a 52-week high of $11.90.

Kindred Healthcare (NYSE:KND) last posted its earnings results on Thursday, August 3rd. The health services provider reported $0.19 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.16 by $0.03. Kindred Healthcare had a positive return on equity of 3.49% and a negative net margin of 16.31%. The firm had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same period in the previous year, the company earned $0.38 EPS. The company’s revenue for the quarter was down 4.6% on a year-over-year basis. On average, analysts anticipate that Kindred Healthcare will post $0.22 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This piece was reported by Marea Informative and is the sole property of of Marea Informative. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. and international copyright & trademark law. The legal version of this piece can be viewed at http://www.mareainformativa.com/kindred-healthcare-inc-knd-downgraded-by-zacks-investment-research-to-sell/117532/.

A number of large investors have recently made changes to their positions in KND. Wells Fargo & Company MN grew its position in Kindred Healthcare by 150.8% in the first quarter. Wells Fargo & Company MN now owns 224,631 shares of the health services provider’s stock valued at $1,877,000 after acquiring an additional 135,068 shares during the period. Great West Life Assurance Co. Can boosted its stake in Kindred Healthcare by 5.2% in the first quarter. Great West Life Assurance Co. Can now owns 118,465 shares of the health services provider’s stock worth $984,000 after purchasing an additional 5,848 shares in the last quarter. Comerica Bank boosted its stake in Kindred Healthcare by 3.8% in the first quarter. Comerica Bank now owns 93,993 shares of the health services provider’s stock worth $879,000 after purchasing an additional 3,418 shares in the last quarter. Karp Capital Management Corp acquired a new position in Kindred Healthcare in the first quarter worth $398,000. Finally, Parametric Portfolio Associates LLC boosted its stake in Kindred Healthcare by 7.7% in the first quarter. Parametric Portfolio Associates LLC now owns 555,057 shares of the health services provider’s stock worth $4,635,000 after purchasing an additional 39,643 shares in the last quarter. Hedge funds and other institutional investors own 88.14% of the company’s stock.

About Kindred Healthcare

Kindred Healthcare, Inc, incorporated on March 27, 1998, is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.

Get a free copy of the Zacks research report on Kindred Healthcare (KND)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Kindred Healthcare (NYSE:KND)

Receive News & Stock Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related stocks with our FREE daily email newsletter.